Previous 10 | Next 10 |
Summary When I think about the lessons learned from 2022, I think the biggest lesson is valuations matter. I do think this is the most predicted recession that I've ever seen, certainly, in my career. Investors of all stripes, whether you're an asset allocator or a stock picker, I t...
Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...
Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...
Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...
Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...
Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...
Summary Global business conditions worsened in the penultimate month of the year according to the JPMorgan Global Composite PMI, compiled by S&P Global. New order expansions were seen in merely three of the 21 sectors tracked by the global PMI - software & services, pharmaceutic...
Summary Expectations surrounding central bank policy, China’s gradual reopening and a lower US dollar are key to investor sentiment in the final stretch of 2022. Central banks have increased interest rates at the fastest rate on record, and there are signs that higher yields are ...
Summary Surging stocks show markets believe hopes of a soft landing by the Fed to be true. We disagree and stay underweight developed market (DM) stocks. U.S. stocks jumped and bond yields plunged after October CPI rose less than the market expected. But sticky core inflation keep...
Summary U.S. midterm elections: Win, lose or draw for markets? What sectors may benefit from a divided government. Will equity markets get the post midterm election bump? For further details see: U.S. Midterm Elections: Win, Lose Or Draw For Markets? ...
News, Short Squeeze, Breakout and More Instantly...
ETFMG Treatments Testing and Advancements Company Name:
GERM Stock Symbol:
NYSE Market:
CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9 billion in assets across its suite of ETFs (as of 5/31/2024). Amplify ETFs deliver expanded in...
CHICAGO, March 26, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces March income distributions for its ETFs. About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9.1 billion in assets across its suite of ETFs (as of 1/26/2024). Amplify ETFs deliver expanded ...
CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which consist of over $3.7 billion of assets under management (AUM) across 14 ETFs (as of 1/26/2024). Ampl...